Key Contacts

contact details for our global offices
USA: +1 650 252 0002
UK: +44 203 670 2007
email: info@ndb.technology

Recent News

Recent Tweets

We consider electric vehicles to replace the conventional cars, but their power or fuel capacity isn’t enough to ha… https://t.co/IYjshndPRz
Dr. Suguru Amakubo
Chief Technology Officer
+1 650 2520 002 Ext. 105

 

Suguru F. Amakubo, Ph.D., M.Sc., B.Sc.

 

Dr. Suguru Amakubo is the Chief Technology Officer (CTO) of the technology conglomerate ORBTM Group. Who in the past has worked at the prestigious London Centre for Nanotechnology (LCN, University College London (UCL), 4th in the QS World Ranking 2014, UK).

 

Dr. Suguru Amakubo is a nanotechnologist that specializes in the field of carbon nano-materials with extensive knowledge in sp2 and sp3 carbons such as the Nobel prize winning material graphene, carbon nanotube, fullerene, nano-diamonds,ultra-crystalline diamonds and polymer composites. At NDB, Dr. Amakubo has utilised these materials in making betavoltaics, diamond radiation shields, nuclear diamond and radioisotope purification amongst many others.

 

During his time at UCL, Dr. Amakubo has developed devices for the latest generation Trident Nuclear Submarine for the Ministry of Defence, Royal Navy (UK) with BAE Systems and UCL. Devices with further application in nuclear disaster relief such as Chernobyl and Fukushima.

 

Dr. Suguru Amakubo has also developed signal intensifiers for night vision technology that are to be used by both the military and civilians. Additionally, he has worked on the development of nano-machine based heart failure sensors by utilizing the piezo-resistive nature of nano-carbon polymer composites.

 

Dr. Suguru Amakubo has received his PhD from UCL in electrical engineering, masters from UCL in nanotechnology and his bachelors from UCL in physics.

 

Suguru is currently pontificating across multiple disciplinaries to develop new age technologies which include green energy waste recycling solutions and the development of ‘smartphone-like’ drugs platform that allows for drugs to be customized to add features in a similar manner to smartphone apps.

Board of Directors, Executive Team